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This bibliography includes documents and websites/webpages reviewed in conducting research for my 3L
paper, “Bioterrorism and the Food and Drug Administration: H.R. 3448, Related Legislation, and the
FDA’s Expanding Role in Preventing and Responding to Biological Attack.” In researching this paper, I
reviewed a large number of documents related to bioterrorism, the role of the Food and Drug Administration
(FDA) in preventing and responding to bioterrorism, and related topics. Because my paper was narrowly
focused on HR3448, I used only a fraction of the useful information I found in the paper itself, and therefore
put together this bibliography in hopes that it might be helpful to someone doing similar research in the
future. It is not exhaustive but does represent a wide sample of available information in this area.
The bibliography includes law review and professional journal articles; useful websites; proposed and exist-
ing laws, regulations, and oﬃcial guidance; government reports and other documents; research institution
reports; media articles; and other documents.
Some Relevant and Useful Websites
Some Relevant General Government Websites
• U.S. Food and Drug Administration (FDA) at www.fda.gov.
• U.S. Centers for Disease Control and Prevention (CDC) at www.cdc.gov.
• U.S. Department of Health and Human Services (DHHS) at www.hhs.gov.
• Government Food Safety website at www.foodsafety.gov
(Cooperative eﬀort by U.S. Food and Drug Administration, Department of Agriculture, Environ-
mental Protection Agency, Centers for Disease Control and Prevention)
δ National Food Safety Programs page at http://www.foodsafety.gov/∼dms/fs-toc.html
• General Accounting Oﬃce at www.gao.gov
(Federal reports on many topics–includes terrorism report link)
1• House Committee on Energy and Commerce website at http://energycommerce.house.gov/.
• Oﬃce of Homeland Security website at http://www.whitehouse.gov/homeland/.
• THOMAS: Legislative Information on the Internet [hereinafter “THOMAS”], a service of the Library of
Congress, at www.thomas.loc.gov.
2Some Government Counter-terrorism and Disaster Prevention Websites
• The Center for Nonproliferation Studies at the Monterey Institute of International Studies
• Critical Infrastructure Assurance Oﬃce at www.ciao.gov
(Per the webwebsite, the CIAO was established in 1996 to “address the vulnerabilities created in
the new information age,” and to, “formulate a comprehensive national strategy for protecting the
infrastructures we all depend on from physical and ‘cyber’ threats.”)
• National Infrastructure Protection Center at www.nipc.gov
(Per the webwebsite, the NIPC “serves as a national critical infrastructure threat assessment, warn-
ing, vulnerability, and law enforcement investigation and response entity.”)
Some General Non-government Counter-terrorism and Disaster Prevention Websites
• Center for Nonproliferation Studies (CNS) at the Monterey Institute of International Studies at www.cns.miis.edu.
• Twenty-ﬁrst (21st) Century Disasters at www.globaldisaster.org
(includes pages speciﬁc to nuclear-biological-chemical terrorism and cyberterrorism)
• Federation of American Scientists at www.fas.org
(includes pages speciﬁc to terrorism)
Some Government and Non-government Bioterrorism-speciﬁc Websites
• Center for Nonproliferation Studies (CNS)’s “Chemical and Biological Weapons Resource Page” at http://cns.miis.edu/research/cbw/response.htm,
last visited Apr. 25, 2002.
• DHHS’s “Anthrax and Biological Incidents: Preparedness and Response” page at http://www.hhs.gov/hottopics/healing/biological.html,
last revised Apr. 1, 2002.
• FDA’s general “Bioterrorism” information page at http://www.fda/gov/oc/opacom/hottopics/bioterrorism.html
3(last viewed Apr. 24, 2002; last updated Mar. 8, 2002).
• FDA’s Center for Biologics Evaluation and Research (CBER)’s “Countering Bioterrorism” page at http://www.fda.gov/cber/cntrbio/cntrbio.htm,
last updated Mar. 29, 2002.
• FDA’s Center for Food Safety and Applied Nutrition (CFSAN)’s “Food Safety and Terrorism” page at
http://www.cfsan.fda.gov/∼dms/fsterr.html.
• www.FoodSafety.gov’s “Countering Bioterrorism and Other Threats to the Food Supply” page at http://www.foodsafety.gov/∼fsg/bioterr.html,
last updated Jan. 9, 2002.
• CDC’s “Public Health Emergency Preparedness & Response” page at http://www.bt.cdc.gov/, last up-
dated Apr. 10, 2002.
• Hardin Library for the Health Sciences at the University of Iowa’s “Hardin MD Focus Page: Bioterror-
ism/Biological Warfare” page at http://www.lib.uiowa.edu/hardin/md/bioterrorism.html.
• Johns Hopkins University’s Center for Civilian Biodefense Strategies website at http://www.hopkins-
biodefense.org/index.html.
• MEDLINE’s “MEDLINEplus: Biological and Chemical Weapons” page at http://www.nlm.nih.gov/medlineplus/biologicalandchemicalweapons.html.
• Saint Louis University’s Center for the Study of Bioterrorism and Emerging Infections website at http://bioterrorism.slu.edu/.
• Twenty-ﬁrst (21st) Century Disasters: Nuclear-Biological-Chemical Terrorism Resource Center at www.globaldisaster.org/nbcrescen.shtml
(links to relevant articles and websites)
Government and Non-government Cyberterrorism-speciﬁc Websites
• Carnegie Mellon Computer Emergency Response Team (CERT) Coordination Center) at www.cert.org
(key website for cybersecurity–provides reports, alerts, recommendations)
• Counterpane Internet Security at www.counterpane.com
(private company with large archive of reports of cybersecurity breaches and attacks)
4• Federation of American Scientists’ Intelligence Resource Program: CyberSecurity Intelligence Threat As-
sessments at http://www.fas.org/irp/threat/cyber/index.html
• The Institute for Security Technology Studies at Dartmouth College at http://www.ists.dartmouth.edu/
• Institute for the Advanced Study of Information Warfare at www.psycom.net/iwar.1.html
(this website provides a large number of useful links to related articles and websites)
• Twenty-ﬁrst (21st) Century Disasters: Cyberterrorism Resource Center at www.globaldisaster.org/cyberterrorrescen.shtml
(links to relevant articles and websites)
5Some Senators’ and Representatives’ websites and pages with bioterrorism information:
• Congressman Gary Miller at http://www.house.gov/garymiller/
(as of April 24, 2002, this website included relevant “Information Links & Biological Threat Fact
Sheets”)
• Congressman W.J. “Billy” Tauzin at http://www.house.gov/tauzin
(Representative Tauzin is a House sponsor of H.R. 3448)
Some Relevant FDA Rules/Guidelines/Notices:
• FDA Proposed Rule, New Drug and Biological Drug Products; Evidence Needed to Demonstrate Eﬃcacy
of New Drugs for Use Against Lethal or Permanently Disabling Toxic Substances When Eﬃcacy Studies
in Humans Ethically Cannot Be Conducted, 64 Fed. Reg. 53960 (proposed Oct. 5, 1999), Docket No.
98N-0237, OC 9818.
• FDA Notice, Prescription Drug Products; Doxycycline and Penicillin G Procaine Administration for In-
halational Anthrax (Post-Exposure), Docket No. 01N-0494.
• FDA Notice, Food Security Guidance; Availability, Jan. 9, 2002, Docket No. 01D-0583, Federal Register
Vol. 67, No. 6, Pages 1224-25.
• FDA Guidance for Industry, Food Producers, Processors, Transporters, and Retailers: Food Security
Preventive Measures Guidance, Jan. 9, 2002.
• FDA Guidance for Industry, Importers and Filers: Food Security Preventive Measures Guidance, Jan. 9,
2002.
• FDA Final Guidance, Guidance for Industry: Recommendations for Assessment of Donor Suitability and
Blood and Blood Product Safety in Cases of Possible Exposure to Anthrax, Oct. 2001.
Some Relevant Bills and Laws
Bills
6• Bioterrorism Preparedness Act of 2001, H.R. 3448, 107th Congress (2001).
• Bioterrorism Preparedness Act of 2001, S. 1765, 107th Congress (2001).
Laws
• Department of Defense and Emergency Supplemental Appropriation for Recovery From and Response to
Terrorist Attacks on the United States Act, 2002, Pub. L. No. 107-117, 115 Stat. 2230.
• Food, Drug, and Cosmetic Act.
• Federal Anti-Tampering Act.
• Uniting and Strengthening America by Providing Appropriate Tools Required to Intercept and Obstruct
Terrorism (USA PATRIOT ACT) Act of 2001, Pub. L. No. 107-56, 115 Stat. 272.
Legislative History/Bill Status Updates
• Bill Summary & Status File for H.R. 3448, from THOMAS, reviewed periodically and last viewed Apr.
29, 2002.
• Bill Summary & Status File for S. 1765 (Introduced in Senate), from THOMAS, reviewed periodically and
last viewed Apr. 24, 2002.
Government-Produced or -Sponsored Reports
• GAO Report, Anthrax Vaccine: Changes to the Manufacturing Process, General Accounting Oﬃce, Doc.
No. GAO-02-181-T, Oct. 23, 2001, available at http://www.gao.gov/terrorism.html.
• GAO Report, Combating Terrorism: Considerations for Investing Resources in Chemical and Biolog-
ical Preparedness, General Accounting Oﬃce, Doc. No. GAO-02-162T, Oct. 17, 2001, available at
http://www.gao.gov/terrorism.html.
7• GAO Report, Food Safety: Agencies Should Further Test Plans for Responding to Deliberate Contamina-
tion, Doc. No. RCED-00-3, Oct. 27, 1999, available at http://www.gao.gov/terrorism.html.
• Food Safety Progress Report: Fiscal Year 2000, U.S. Food and Drug Administration, Aug. 2000, available
at http://www.cfsan.fa.gov/∼dms/fsirp00.html.
• NSTC Report, Global Microbial Threats in the 1990s, NSTC Committee on International Science, available
at http://www.ostp.gov/CISET/html/toc.html, last viewed Jan. 30, 2002.
• Workshop Report, Medical Defense Against Bioterrorism: Eﬃcacy and Safety of New Products Workshop,
Organized by FDA’s Center for Biologics Evaluation and Research in Cooperation with the Department
of Defense, held Dec. 6-7, 2000, available at http://www.fda.gov/cber/meetings/bioterr120600.htm (last
updated Jan. 12, 2001) (a workshop agenda and outlines of many presentations are available).
• Report Abstract, Critical Infrastructure Protection: Signiﬁcant Challenges in Developing Analysis, Warn-
ing, and Response Capabilities, GAO-01-1005T, U.S. General Accounting Oﬃce, Jul. 25, 2001, available at
www.gao.gov.
Government-Produced Workplans, Press Releases, Fact Sheets, Fact Pages, etc.
• Consumer Alert, Oﬀers to Treat Biological Threats: What You Need to Know, Federal Trade Commission
(in cooperation with CDC and FDA), Oct. 2001, available at http://www.ftc.gov/bcp/conline/pubs/alerts/bioalrt.htm.
• Consumer Information, Dietary Supplements Claiming to Prevent or Treat Anthrax, U.S. Food and Drug
Administration: Center for Food Safety and Applied Nutrition, last updated Nov. 8, 2001, available at
http://www.cfsan.fda.gov/∼dms/danthrx.html.
• FDA FY 2003 Annual Performance Plan: FY 2002 Revised Final Performance Plan: FY 2001 Annual Per-
formance Report, U.S. Food and Drug Administration, Feb. 2002, available at http://www.fda.gov/ope/FY03plan/default.htm.
• Work Plan Fiscal Year 2000, Department of Health and Human Services Documents, Practising Law
Institute, Corporate Law and Practice Course Handbook Series, PLI Order No. B0-00IU, May 1-2, 2000
(includes brief description of FDA’s bioterrorism research program).
• “DHHS Requests Over $104 Million for FDA to Combat Bioterrorism,” U.S. Food and Drug Administra-
tion, Oﬃce of Public Aﬀairs (Oct. 31, 2001) available at http://www.fda.gov/oc/bioterrorism/budget.html.
• Fact Sheet, HHS Initiative Prepares for Possible Bioterrorism Threat, U.S. Department of Health and Hu-
8man Services, Aug. 16, 2001, available at http://www.hhs.gov/news/press/2001pres/01fsbioterrorism.html,
last revised Oct. 6, 2001.
• Fact Sheet, U.S. Food and Drug Administration, FDA and the Drug Development Process: How the
Agency Ensures that Drugs are Safe and Eﬀective, Pub. No. FS 02-1, Feb. 2002, available at www.fda.gov.
• Fact Sheet, U.S. Food and Drug Administration, FDA Protects the Public’s Health; Ranks High in Public
Trust, Feb. 2002, available at www.fda.gov.
• Fact Sheet, U.S. Food and Drug Administration, FDA’s Global Shield for American Consumer: The
Agency Acts World-Wide to Ensure High Quality Imports, Pub. No. FS 01-12, revised Feb. 2002, available
at www.fda.gov.
• Fact Sheet, U.S. Food and Drug Administration, Human Subject Protection: FDA’s Role in a System of
Safeguards, Pub. No. FS 01-11, revised Feb. 2002, available at www.fda.gov.
• Fact Sheet, U.S. Food and Drug Administration, Keeping the Nation’s Food Supply Safe: FDA’s Big Job
Done Well, revised Feb. 2002, available at www.fda.gov.
• Fact Page, Anthrax, U.S. Food and Drug Administration: Center for Biologic Evaluation and Research,
last updated Apr. 8, 2002, available at http://www.fda.gov/cber/vaccine/anthrax.htm.
• Fact Page, Countering Bioterrorism Initiative, U.S. Food and Drug Administration: Center for Biologics
Evaluation and Research, last updated Apr. 17, 2002, available at http://www.fda.gov/cber/cntrbio/cntrbio.htm.
• Fact Page, Countering Bioterrorism: Frequently Asked Questions (FAQs), U.S. Food and Drug Ad-
ministration: Center for Biologic Evaluation and Research, last updated Oct. 11, 2001, available at
http://www.fda.gov/cber/faq/cntrbfaq.htm.
• Fact Page, Frequently Asked Consumer Questions About Food Safety and Terrorism, U.S. Food and Drug
Administration: Center for Food Safety and Applied Nutrition, last updated Jan. 16, 2002, available at
http://www.cfsan.fda.gov/∼dms/fsterrqa.html.
• Fact Page, Hiring Initiative for Countering Bioterrorism, U.S. Food and Drug Administration: Center for
Biologics Evaluation and Research, last updated Dec. 14, 2001, available at http://www.fda.gov/cber/inside/btihire.htm.
• Fact Page, Leveraging at FDA: Creating Solutions Through Partnerships with Stakeholders, U.S. Food and
Drug Administration, last visited Apr. 25, 2002, available at http://www.fda.gov/oc/leveraging/activities.html
9and at http://www.fda.gov/oc/leveraging/default.htm.
• Mission Statement, “FDA’s Mission,” U.S. Food and Drug Administration, last updated Oct. 19, 1998,
available at http://www.fda.gov/opacom/morechoics/mission.html.
• Organization Charts, “FDA Organization Charts,” U.S. Food and Drug Administration, last updated
Apr. 9, 2002, available at http://www.fda.gov/oc/orgcharts/orgchart.html (organizational charts for various
oﬃces and centers of FDA).
• Press Release, Defending Against Biological Terrorism, Oﬃce of the Press Secretary, U.S. White House,
Feb. 5, 2002, available at http://www.whitehouse.gov/news/releases/2002/02/20020205-1.html.
• Press Release, HHS Accelerates Bioterrorism Research: New Programs Expedite Ideas from Concerned Sci-
entists, U.S. Department of Health and Human Services, Dec. 6, 2001, available at http://www.hhs.gov/news/press/2001pres/20011206a.html.
• Press Release, HHS Initiative Prepares for Possible Bioterrorism Threat, U.S. Department of Health and
Human Services, May 18, 2000, available at http://www.hhs.gov/news/press/2000pres/20000518.html.
• Press Release, HHS May Acquire More Than 75 Million Doses of Smallpox Vaccine: Agreement Would
Require That Vaccine Being Proven Safe and Eﬀective, U.S. Department of Health and Human Services,
Mar. 29, 2002, available at http://www.hhs.gov/news/press/2002pres/20020329.html.
• Press Release, Secretary Thompson Testiﬁes on HHS Readiness and Role of Vaccine Research and Develop-
ment, U.S. Department of Health and Human Services, Oct. 23, 2001, available at http://www.hhs.gov/news/press/2001pres/20011023.html.
• Summary Report for Lawmakers and Public, “FDA’s Growing Responsibilities for the Year 2001 and Be-
yond,” U.S. Food and Drug Administration, last updated June 13, 2001, available at http://www.fda.gov/oc/opacom/budgetbro/budgetbro.html.
• “Years and Session Dates of the U.S. Congress,” U.S. Government Printing Oﬃce, available at www.access.gpo.gov.
Some Research Institute and Similar Entity Reports, Articles, etc.
• Michael A. Vatis, Cyber Attacks During The War on Terrorism: A Predictive Analysis, Institute for Secu-
rity Technology Studies at Dartmouth College, Sep. 22, 2001, available at http://www.ists.dartmouth.edu/.
• Tara O’Toole, M.D., Summary of Lessons Learned: Shining Light on Dark Winter, The Johns Hopkins Uni-
10versity Center for Civilian Biodefense Studies (2001), available at http://www.hopkins-biodefense.org/lessons.html.
• Funding Chart, Federal Funding to Combat Terrorism, Including Defense Against Weapons of Mass De-
struction: FY 1998-2001, Center for Nonproliferation Studies at Monterey Institute of Intenational Studies,
last updated Jul. 2000, available at http://cns.miis.edu/research/cbw/terfund.htm.
• Organizational Chart, United States Response to CBW Terrorism and Domestic Preparedness: Organiza-
tional Chart for Terrorism Response, Center for Nonproliferation Studies at Monterey Institute of Intena-
tional Studies, last updated Oct. 21, 2001, available at http://cns.miis.edu/research/cbw/domestic.htm.
• Overview of Attack Trends, CERTr  Coordination Center, available at http://www.cert.org/archive/pdf.PDF
(last viewed Apr. 17, 2002) (addresses current trends in cyberattacks, including speed of attack, sophistica-
tion of tools, discovery and exploitation of vulnerabilities and permeability of ﬁrewalls).
• Timothy Shimeall et al., Countering cyber war, NATO Review, Winter 2001/2002, available at http://www.cert.org/archive/pdf/counter cyberwar.pdf.
• Phil Williams et al., Intelligence Analysis for Internet Security, CERTr  Coordination Center, available at
http://www.cert.org/archive/html/Analysis10a.html (last viewed Apr. 17, 2002).
• International Coordination for Cyber Crime and Terrorism in the 21st Century, available at http://www.cert.org/reports/stanford whitepaper V6.pdf
(last viewed Apr. 17, 2002).
Casebooks and Treatises
• Peter Barton Hutt & Richard A. Merrill, Food and Drug Law: Cases and Materials (2d ed.) (1991).
Some Relevant Law Review and Other Professional Journal Articles
• Special Issue: Symposium on Medical and Public Health Responses to Bioterrorism, Emerging Infectious
Diseases, Vol. 5, No. 4, July-August 1999, available at http://www.cdc.gov/ncidod/eid/vol5no4/contents.htm.
• George J. Annas, The Man on the Moon, Immortality, and other Millennial Myths: The Prospects and
Perils of Human Genetic Engineering, 49 Emory Law Journal (2000) (brieﬂy addresses the potential use of
genetically engineered organisms in bioterrorism–see p. 7 and fn. 66).
• LTC George Christopher, et al., Biological Warfare: A Historical Perspective, Journal of the American
11Medical Association (JAMA), Vol. 278, No. 5, Aug. 6, 1997.
• Thomas B. Cole, When a Bioweapon Strikes, Who Will Be in Charge?, Journal of the American Medical
Association (JAMA), Vol. 284, No. 6, Aug. 23/30, 2000.
• Heather A. Dagen, Bioterrorism: Perfectly Legal, 49 Catholic University Law Review 535 (2000).
• Caroline Smith DeWaal, Food Safety Inspections: A Call for Rational Reorganization, 54 Food and Drug
Law Journal 453 (1999).
• James R. Feguson, Biological Weapons and US Law, Journal of the American Medical Association (JAMA),
Vol. 278, No. 5, Aug. 6, 1997.
• Julie Louise Gerberding et al., Bioterrorism Preparedness and Response: Clinicians and Public Health
Agencies as Essential Partners, Journal of the American Medical Association (JAMA), Vol. 287, No. 7, Feb.
20, 2002.
• Donna M. Gitter, International Conﬂicts Over Patenting Human DNA Sequences in the United States
and the European Union: An Argument for Compulsory Licensing and a Fair-Use Exemption, 76 New York
University Law Review 1623 (2001) (brieﬂy references the potential applicability of compulsory licensing
and/or government “march-in” rights in combatting bioterrorist attacks–see fn. 381).
• T.W. Hennessy et al., A national outbrak of salmonella enteritidis infections from ice cream, New England
Journal of Medicine, Vol. 334: 1281-86 (1996).
• Willian E. Keene, Lesson From Investigations of Foodborne Disease Outbreaks, Journal of the American
Medical Association (JAMA), Vol. 281, No. 19, May 19, 1999.
• Barry Kellman, Biological Terrorism: Legal Measures for Preventing Catastrophe, 24 Harvard Journal of
Law and Public Policy 417 (2001).
• Barry Kellman, Catastrophic Terrorism–Thinking Fearfully, Acting Legally, 20 Michigan Journal of Inter-
national Law 537 (1999).
• Barry Kellman, An International Criminal Law Approach to Bioterrorism, 25 Harvard Journal of Law and
Public Policy 721 (2002).
12• Barry Kellman and Stephen Dycus, International Security, 34 International Lawyer 799 (2000).
• Ali S. Khan et al., Precautions Against Biological and Chemical Terrorism Directed at Food and Water
Supplies, Public Health Reports, Vol. 116, pp. 3-14, Jan.-Feb., 2001.
• Ali S. Khan et al., Public-health Preparedness for Biological Terrorism in the USA, The Lancet 356 (9236):
1179-1182, sep. 30, 2000.
• Shellie A. Kolavic et al., An Outbreak of Shigella dysenteriae Type 2 Among Laboratory Workers Due to
Intentional Food Contamination, Journal of the American Medical Association (JAMA), Vol. 278, No. 5,
Aug. 6, 1997.
• Mark G. Kortepeter & Gerald W. Parker, Potential Biological Weapons Threats, in Special Issue: Sym-
posium on Medical and Public Health Responses to Bioterrorism, Emerging Infectious Diseases, Vol. 5, No.
4, July-August 1999, available at http://www.cdc.gov/ncidod/eid/vol5no4/kortepeter.htm.
• Christina M. Markus, FDA Fights Flexibly: Agency must ensure that our best biotech can battle bioter-
rorism, Legal Times, Vol. 24, No. 44, Nov. 5, 2001.
• Richard A. Merrill & Jeﬀrey K. Francer, Organizing Federal Food Safety Regulation, 31 Seton Hall Law
Review 61 (2000).
• Eric A. Posner, Fear and the Regulatory Model of Counterterrorism, 25 Harvard Journal of Law and Public
Policy 681 (2002).
• David Satcher, The History of the Public Health Service nd the Surgeon General’s Priorities, 54 Food and
Drug Law Journal 13 (1999).
• Jeremy Sobel et al., Threat of a biological terrorist attack on the US food supply: the CDC perspective,
The Lancet, 359 (9309), 874-880, Mar. 9, 2002.
• Joan Stephenson, Biowarfare Warning, Journal of the American Medical Association (JAMA), Vol. 285,
No. 6, Feb. 14, 2001.
• Thomas J. T¨ or¨ ok et al., A Large Community Outbreak of Salmonellosis Caused by intentional Contami-
nation of Restaurant Salad Bars, Journal of the American Medical Association (JAMA), Vol. 278, No. 5,
13Aug. 6, 1997.
• Rebecca Voelker, Bioweapons Preparedness Chief Discusses Priorities in World of 21st-Century Biology,
Journal of the American Medical Association (JAMA), Vol. 287, No. 5, Feb. 6, 2002.
• Kathryn C. Zoon, Vaccines, Pharmaceutical Products, and Bioterrorism: Challenges for the U.S. Food
and Drug Administration, 5 Emerging Infectious Diseases 534, Jul.-Aug. 1999 (Special Issue).
News Articles, non-Government Press Releases, and other Press Resources
• CNN.com In-Depth Special on biological and chemical weapons available at http://www.cnn.com/SPECIALS/2001/trade.center/biochem.weapons/.
• Press Release, NFPA Says FDA Food Security Guidance Strengthens Barriers to Food Security Threats,
National Food Producers Institute, Jan. 8, 2002, available at www.nfpa-food.org.
• Flu drug sales a terrorism tip-oﬀ?, CNN.com/HEALTH, Apr. 16, 2002, available at http://www.cnn.com/2002/HEALTH/04/16/detecting.anthrax.ap/index.html.
• House Approves Bioterror Bills, Wired.com, Dec. 12, 2001, available at http://www.wired.com/news/conﬂict/0,2100,49094,00.html.
• Jason Pate, Better Plan Needed for Curbing Epidemics, Newsday, p. A-43, Nov. 29, 2000, available at
http://cns.miis.edu/pubs/reports/patend.htm.
• Julie Rovner, Experts Tell Senate US Not Ready for Bioterror, Reuters Health, Apr. 18, 2002, available
at http://www.nlm.nih.gov/medlineplus/news/fullstory 7194.html.
• John Milburn, Oﬃcials Discuss Food Vulnerability, Associated Press, Mar. 26, 2002, available at http://www.nlm.nih.gov/medlineplus/news/fullstory 6791.html.
• Jeﬀrey McMurray, Senator Proposes Bioterrorism Hub, Associated Press, Apr. 3, 2002, available at
http://www.hlm.nih.gov/medlineplus/news/fullstory 6942.html.
• Peggy Peck, Doctors Line Up for Bioterror Info, UPI Science News, Apr. 12, 2002, available at http://www.hlm.nih.gov/medlineplus/news/fullstory 7131.html.
• Jeanne Meserve, FDA to propose antiterrorist food safety guidelines, CNN.com, Jan. 8, 2002, available at
14http://www.cnn.com/2002/US/01/08/rec.food.safety.terrorists/index.html.
Presentations, Press Releases, Floor Statements, etc. by Public Oﬃcials and Committees
• Committee News Release, “Tauzin Hails House Passage of Sweeping Bioterrorism Bill,” U.S. House Com-
mittee on Energy and Commerce, Dec. 12, 2001, available at http://energycommerce.ouse.gov/107/new/12122001 454.htm.
• Speech, “Food Safety and America’s Future,” Tommy G. Thompson, Secretary of Health and Human
Services, at meeting of the National Food Processors Association, Washington, D.C., Nov. 27, 2001, available
at http://www.hhs.gov/news/speech/2001/011127.html.
• Press Conference Statement and Floor Statement, Rep. John D. Dingell, “H.R. 3448, The Public Health Se-
curity and Bioterrorism Response Act of 2001,” Dec. 11, 2001, available at http://www.house.gov/commerce democrats/press/107st75.htm.
Some Relevant Testimony Before Congress (in reverse chronological order)
• Statement of D.A. Henderson, M.D., Director, Oﬃce of Public Health Preparedness, Department of Health
and Human Services, The Science of Bioterrorism: HHS Preparedness, before the House Committee on
Science, Dec. 5, 2001, available at http://www.hhs.gov/asl/testify/t011205.html.
• Statement of Scott R. Lillibridge, M.D., Special Assistant to the Secretary for National Security and Emer-
gency Management, Department of Health and Human Services, Restructuring Government for Homeland
Security: Nuclear/Biological/Chemical Threats, before the House Committee on the Budget, Dec. 5, 2001,
available at http://www.hhs.gov/asl/testify/t011205a.html.
• Statement of Tommy G. Thompson, Secretary, Department of Health and Human Services, Federal Eﬀorts
to Coordinate and Prepare for Bioterrorism: The HHS Role, before the Senate Committee on Governmental
Aﬀairs and Subcommittee on International Security, Proliferation and Federal Services, Oct. 17, 2001
(available at http://www.hhs.gov/asl/testify/t011017.html.
• Statement of Claude A. Allen, Deputy Secretary, Department of Health and Human Services, The Role
of HHS’s Oﬃce of Emergency Preparedness in the Federal Response Plan, before the Senate Committee on
Veteran’s Aﬀairs, Oct. 16, 2001, available at http://www.hhs.gov/asl/testify/011016.html.
• Statement of Scott R. Lillibridge, M.D., Special Assistant to the Secretary for National Security and Emer-
gency Management, Department of Health and Human Services, HHS Bioterrorism Preparedness, before the
15House Committee on Energy and Commerce, Subcommittee on Oversight and Investigations, Oct. 10, 2001,
available at http://www.hhs.gov/asl/testify/t011010a.html.
• Statement [on food safety] of Bernard A. Schwetz, D.V.M., Ph.D., Acting Principal Deputy Commissioner,
U.S. Food and Drug Administration, before the Committee on Governmental Aﬀairs, Subcommittee on
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